Overview

Dexamethasone for Migraine - Dose Comparison

Status:
Recruiting

Trial end date:
2022-07-27

Target enrollment:

Participant gender:

Summary

Dexamethasone is an evidence-based treatment of acute migraine. This is a randomized comparison of two different doses of dexamethasone for acute migraine. All patients will also be treated with metoclopramide.

Phase:

Phase 4

Details

Lead Sponsor:

Montefiore Medical Center

Treatments:

BB 1101
Dexamethasone
Dexamethasone acetate